AON
65
3
ROST
68
-3
BF.B
39
-3
PCG
77
3
IFF
59
2
THC
48
2
AXP
74
4
EOG
37
4
ALLE
46
2
PH
64
2
LH
48
5
HP
41
3
XRX
34
-4
R
67
4
PAYX
41
5
LUV
70
2
VIX
19
-6
FSLR
78
5
SRE
47
2
PRGO
43
4
AON
65
3
ROST
68
-3
BF.B
39
-3
PCG
77
3
IFF
59
2
THC
48
2
AXP
74
4
EOG
37
4
ALLE
46
2
PH
64
2
LH
48
5
HP
41
3
XRX
34
-4
R
67
4
PAYX
41
5
LUV
70
2
VIX
19
-6
FSLR
78
5
SRE
47
2
PRGO
43
4
Financhill
Back

Contineum Therapeutics, Inc. 10K Form

Buy
62

CTNM
Contineum Therapeutics, Inc.

Last Price:
$12.34
Seasonality Move:
-24.83%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CTNM News And Ratings

See the #1 stock for the next 7 days that we like better than CTNM

CTNM Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-12.4M
Price / Cash Flow: 23.72
Annual Sales: $6.18
Price / Book: 1.76

Profitability

EPS (TTM): -2.25580
Net Income (TTM): $-59.4M
Gross Margin: $-258K
Return on Equity: -31.42%
Return on Assets: -29.67%

Contineum Therapeutics, Inc. Earnings Forecast

Key Contineum Therapeutics, Inc. Financial Ratios

  • Per Share Earnings over the last 4 years have been positive in 2 years.

Contineum Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: CTNM
Website: contineum-tx.com

Debt

Debt-to-Equity Ratio: 0.03
Current Ratio: 29.07
Quick Ratio: 28.68

Price-to-Earnings

Trailing P/E Ratio: 6.04
Forward P/E Ratio: 0

CTNM Technical Analysis vs Fundamental Analysis

Buy
62
Contineum Therapeutics, Inc. (CTNM) is a Buy

Is Contineum Therapeutics, Inc. a Buy or a Sell?